Clinical Trial Update: Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow [Phase 2]

View source ↗

Summary

Phase 2 trial update on specialized blood cell transplants for cancers of the blood and bone marrow; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome
• Myeloproliferative Disorders

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myeloproliferative Disorders, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-10-07